▶ 調査レポート

世界の豚呼吸器疾患治療市場 2021:企業別、地域別、種類・用途別

• 英文タイトル:Global Swine Respiratory Diseases Treatment Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Global Swine Respiratory Diseases Treatment Market 2021 by Company, Regions, Type and Application, Forecast to 2026「世界の豚呼吸器疾患治療市場 2021:企業別、地域別、種類・用途別」(市場規模、市場予測)調査レポートです。• レポートコード:GIR-107A11920
• 出版社/出版日:GlobalInfoResearch / 2021年7月20日
• レポート形態:英文、PDF、105ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、豚呼吸器疾患治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。豚呼吸器疾患治療の種類別市場規模(マイコプラズマ、バクテリア、ウイルス、その他)、用途別市場規模(獣医病院、獣医クリニック、薬局、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・豚呼吸器疾患治療の市場概要
・企業情報(企業概要、製品概要、販売量、価格、売上):Zoetis、Virbac、Eli Lilly(Elanco)、Merck Animal Health、Boehringer Ingelheim、Ceva Sante Animale、Norbrook、Thermo Fisher Scientific Inc、Vetoquinol、Bimeda holdings PLC、Huvepharma
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:マイコプラズマ、バクテリア、ウイルス、その他
・用途別分析2016年-2026年:獣医病院、獣医クリニック、薬局、その他
・豚呼吸器疾患治療の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・豚呼吸器疾患治療のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・豚呼吸器疾患治療のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・豚呼吸器疾患治療の南米市場規模2016年-2026年:ブラジル、アルゼンチン
・豚呼吸器疾患治療の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Swine Respiratory Diseases Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Swine Respiratory Diseases Treatment size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Swine Respiratory Diseases Treatment market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Swine Respiratory Diseases Treatment market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Mycoplasma
Bacteria
Virus
Others

Market segment by Application, can be divided into
Veterinary Hospitals
Veterinary Clinics
Pharmacies
Others

Market segment by players, this report covers
Zoetis
Virbac
Eli Lilly(Elanco)
Merck Animal Health
Boehringer Ingelheim
Ceva Sante Animale
Norbrook
Thermo Fisher Scientific Inc
Vetoquinol
Bimeda holdings PLC
Huvepharma

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

1 Market Overview
1.1 Product Overview and Scope of Swine Respiratory Diseases Treatment
1.2 Classification of Swine Respiratory Diseases Treatment by Type
1.2.1 Overview: Global Swine Respiratory Diseases Treatment Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Swine Respiratory Diseases Treatment Revenue Market Share by Type in 2020
1.2.3 Mycoplasma
1.2.4 Bacteria
1.2.5 Virus
1.2.6 Others
1.3 Global Swine Respiratory Diseases Treatment Market by Application
1.3.1 Overview: Global Swine Respiratory Diseases Treatment Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Veterinary Hospitals
1.3.3 Veterinary Clinics
1.3.4 Pharmacies
1.3.5 Others
1.4 Global Swine Respiratory Diseases Treatment Market Size & Forecast
1.5 Global Swine Respiratory Diseases Treatment Market Size and Forecast by Region
1.5.1 Global Swine Respiratory Diseases Treatment Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Swine Respiratory Diseases Treatment Market Size by Region, (2016-2021)
1.5.3 North America Swine Respiratory Diseases Treatment Market Size and Prospect (2016-2026)
1.5.4 Europe Swine Respiratory Diseases Treatment Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Swine Respiratory Diseases Treatment Market Size and Prospect (2016-2026)
1.5.6 South America Swine Respiratory Diseases Treatment Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Swine Respiratory Diseases Treatment Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Swine Respiratory Diseases Treatment Market Drivers
1.6.2 Swine Respiratory Diseases Treatment Market Restraints
1.6.3 Swine Respiratory Diseases Treatment Trends Analysis
2 Company Profiles
2.1 Zoetis
2.1.1 Zoetis Details
2.1.2 Zoetis Major Business
2.1.3 Zoetis Swine Respiratory Diseases Treatment Product and Solutions
2.1.4 Zoetis Swine Respiratory Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Zoetis Recent Developments and Future Plans
2.2 Virbac
2.2.1 Virbac Details
2.2.2 Virbac Major Business
2.2.3 Virbac Swine Respiratory Diseases Treatment Product and Solutions
2.2.4 Virbac Swine Respiratory Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Virbac Recent Developments and Future Plans
2.3 Eli Lilly(Elanco)
2.3.1 Eli Lilly(Elanco) Details
2.3.2 Eli Lilly(Elanco) Major Business
2.3.3 Eli Lilly(Elanco) Swine Respiratory Diseases Treatment Product and Solutions
2.3.4 Eli Lilly(Elanco) Swine Respiratory Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Eli Lilly(Elanco) Recent Developments and Future Plans
2.4 Merck Animal Health
2.4.1 Merck Animal Health Details
2.4.2 Merck Animal Health Major Business
2.4.3 Merck Animal Health Swine Respiratory Diseases Treatment Product and Solutions
2.4.4 Merck Animal Health Swine Respiratory Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Merck Animal Health Recent Developments and Future Plans
2.5 Boehringer Ingelheim
2.5.1 Boehringer Ingelheim Details
2.5.2 Boehringer Ingelheim Major Business
2.5.3 Boehringer Ingelheim Swine Respiratory Diseases Treatment Product and Solutions
2.5.4 Boehringer Ingelheim Swine Respiratory Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Boehringer Ingelheim Recent Developments and Future Plans
2.6 Ceva Sante Animale
2.6.1 Ceva Sante Animale Details
2.6.2 Ceva Sante Animale Major Business
2.6.3 Ceva Sante Animale Swine Respiratory Diseases Treatment Product and Solutions
2.6.4 Ceva Sante Animale Swine Respiratory Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Ceva Sante Animale Recent Developments and Future Plans
2.7 Norbrook
2.7.1 Norbrook Details
2.7.2 Norbrook Major Business
2.7.3 Norbrook Swine Respiratory Diseases Treatment Product and Solutions
2.7.4 Norbrook Swine Respiratory Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Norbrook Recent Developments and Future Plans
2.8 Thermo Fisher Scientific Inc
2.8.1 Thermo Fisher Scientific Inc Details
2.8.2 Thermo Fisher Scientific Inc Major Business
2.8.3 Thermo Fisher Scientific Inc Swine Respiratory Diseases Treatment Product and Solutions
2.8.4 Thermo Fisher Scientific Inc Swine Respiratory Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Thermo Fisher Scientific Inc Recent Developments and Future Plans
2.9 Vetoquinol
2.9.1 Vetoquinol Details
2.9.2 Vetoquinol Major Business
2.9.3 Vetoquinol Swine Respiratory Diseases Treatment Product and Solutions
2.9.4 Vetoquinol Swine Respiratory Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Vetoquinol Recent Developments and Future Plans
2.10 Bimeda holdings PLC
2.10.1 Bimeda holdings PLC Details
2.10.2 Bimeda holdings PLC Major Business
2.10.3 Bimeda holdings PLC Swine Respiratory Diseases Treatment Product and Solutions
2.10.4 Bimeda holdings PLC Swine Respiratory Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Bimeda holdings PLC Recent Developments and Future Plans
2.11 Huvepharma
2.11.1 Huvepharma Details
2.11.2 Huvepharma Major Business
2.11.3 Huvepharma Swine Respiratory Diseases Treatment Product and Solutions
2.11.4 Huvepharma Swine Respiratory Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Huvepharma Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Swine Respiratory Diseases Treatment Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Swine Respiratory Diseases Treatment Players Market Share
3.2.2 Top 10 Swine Respiratory Diseases Treatment Players Market Share
3.2.3 Market Competition Trend
3.3 Swine Respiratory Diseases Treatment Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Swine Respiratory Diseases Treatment Revenue and Market Share by Type (2016-2021)
4.2 Global Swine Respiratory Diseases Treatment Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Swine Respiratory Diseases Treatment Revenue Market Share by Application (2016-2021)
5.2 Swine Respiratory Diseases Treatment Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Swine Respiratory Diseases Treatment Revenue by Type (2016-2026)
6.2 North America Swine Respiratory Diseases Treatment Revenue by Application (2016-2026)
6.3 North America Swine Respiratory Diseases Treatment Market Size by Country
6.3.1 North America Swine Respiratory Diseases Treatment Revenue by Country (2016-2026)
6.3.2 United States Swine Respiratory Diseases Treatment Market Size and Forecast (2016-2026)
6.3.3 Canada Swine Respiratory Diseases Treatment Market Size and Forecast (2016-2026)
6.3.4 Mexico Swine Respiratory Diseases Treatment Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Swine Respiratory Diseases Treatment Revenue by Type (2016-2026)
7.2 Europe Swine Respiratory Diseases Treatment Revenue by Application (2016-2026)
7.3 Europe Swine Respiratory Diseases Treatment Market Size by Country
7.3.1 Europe Swine Respiratory Diseases Treatment Revenue by Country (2016-2026)
7.3.2 Germany Swine Respiratory Diseases Treatment Market Size and Forecast (2016-2026)
7.3.3 France Swine Respiratory Diseases Treatment Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Swine Respiratory Diseases Treatment Market Size and Forecast (2016-2026)
7.3.5 Russia Swine Respiratory Diseases Treatment Market Size and Forecast (2016-2026)
7.3.6 Italy Swine Respiratory Diseases Treatment Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Swine Respiratory Diseases Treatment Revenue by Type (2016-2026)
8.2 Asia-Pacific Swine Respiratory Diseases Treatment Revenue by Application (2016-2026)
8.3 Asia-Pacific Swine Respiratory Diseases Treatment Market Size by Region
8.3.1 Asia-Pacific Swine Respiratory Diseases Treatment Revenue by Region (2016-2026)
8.3.2 China Swine Respiratory Diseases Treatment Market Size and Forecast (2016-2026)
8.3.3 Japan Swine Respiratory Diseases Treatment Market Size and Forecast (2016-2026)
8.3.4 South Korea Swine Respiratory Diseases Treatment Market Size and Forecast (2016-2026)
8.3.5 India Swine Respiratory Diseases Treatment Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Swine Respiratory Diseases Treatment Market Size and Forecast (2016-2026)
8.3.7 Australia Swine Respiratory Diseases Treatment Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Swine Respiratory Diseases Treatment Revenue by Type (2016-2026)
9.2 South America Swine Respiratory Diseases Treatment Revenue by Application (2016-2026)
9.3 South America Swine Respiratory Diseases Treatment Market Size by Country
9.3.1 South America Swine Respiratory Diseases Treatment Revenue by Country (2016-2026)
9.3.2 Brazil Swine Respiratory Diseases Treatment Market Size and Forecast (2016-2026)
9.3.3 Argentina Swine Respiratory Diseases Treatment Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Swine Respiratory Diseases Treatment Revenue by Type (2016-2026)
10.2 Middle East & Africa Swine Respiratory Diseases Treatment Revenue by Application (2016-2026)
10.3 Middle East & Africa Swine Respiratory Diseases Treatment Market Size by Country
10.3.1 Middle East & Africa Swine Respiratory Diseases Treatment Revenue by Country (2016-2026)
10.3.2 Turkey Swine Respiratory Diseases Treatment Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Swine Respiratory Diseases Treatment Market Size and Forecast (2016-2026)
10.3.4 UAE Swine Respiratory Diseases Treatment Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Swine Respiratory Diseases Treatment Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Swine Respiratory Diseases Treatment Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Swine Respiratory Diseases Treatment Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Swine Respiratory Diseases Treatment Revenue (USD Million) by Region (2016-2021)
Table 5. Global Swine Respiratory Diseases Treatment Revenue Market Share by Region (2021-2026)
Table 6. Zoetis Corporate Information, Head Office, and Major Competitors
Table 7. Zoetis Major Business
Table 8. Zoetis Swine Respiratory Diseases Treatment Product and Solutions
Table 9. Zoetis Swine Respiratory Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Virbac Corporate Information, Head Office, and Major Competitors
Table 11. Virbac Major Business
Table 12. Virbac Swine Respiratory Diseases Treatment Product and Solutions
Table 13. Virbac Swine Respiratory Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Eli Lilly(Elanco) Corporate Information, Head Office, and Major Competitors
Table 15. Eli Lilly(Elanco) Major Business
Table 16. Eli Lilly(Elanco) Swine Respiratory Diseases Treatment Product and Solutions
Table 17. Eli Lilly(Elanco) Swine Respiratory Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Merck Animal Health Corporate Information, Head Office, and Major Competitors
Table 19. Merck Animal Health Major Business
Table 20. Merck Animal Health Swine Respiratory Diseases Treatment Product and Solutions
Table 21. Merck Animal Health Swine Respiratory Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Boehringer Ingelheim Corporate Information, Head Office, and Major Competitors
Table 23. Boehringer Ingelheim Major Business
Table 24. Boehringer Ingelheim Swine Respiratory Diseases Treatment Product and Solutions
Table 25. Boehringer Ingelheim Swine Respiratory Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Ceva Sante Animale Corporate Information, Head Office, and Major Competitors
Table 27. Ceva Sante Animale Major Business
Table 28. Ceva Sante Animale Swine Respiratory Diseases Treatment Product and Solutions
Table 29. Ceva Sante Animale Swine Respiratory Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Norbrook Corporate Information, Head Office, and Major Competitors
Table 31. Norbrook Major Business
Table 32. Norbrook Swine Respiratory Diseases Treatment Product and Solutions
Table 33. Norbrook Swine Respiratory Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Thermo Fisher Scientific Inc Corporate Information, Head Office, and Major Competitors
Table 35. Thermo Fisher Scientific Inc Major Business
Table 36. Thermo Fisher Scientific Inc Swine Respiratory Diseases Treatment Product and Solutions
Table 37. Thermo Fisher Scientific Inc Swine Respiratory Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Vetoquinol Corporate Information, Head Office, and Major Competitors
Table 39. Vetoquinol Major Business
Table 40. Vetoquinol Swine Respiratory Diseases Treatment Product and Solutions
Table 41. Vetoquinol Swine Respiratory Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Bimeda holdings PLC Corporate Information, Head Office, and Major Competitors
Table 43. Bimeda holdings PLC Major Business
Table 44. Bimeda holdings PLC Swine Respiratory Diseases Treatment Product and Solutions
Table 45. Bimeda holdings PLC Swine Respiratory Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Huvepharma Corporate Information, Head Office, and Major Competitors
Table 47. Huvepharma Major Business
Table 48. Huvepharma Swine Respiratory Diseases Treatment Product and Solutions
Table 49. Huvepharma Swine Respiratory Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Global Swine Respiratory Diseases Treatment Revenue (USD Million) by Players (2019-2021)
Table 51. Global Swine Respiratory Diseases Treatment Revenue Share by Players (2019-2021)
Table 52. Breakdown of Swine Respiratory Diseases Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 53. Swine Respiratory Diseases Treatment Players Head Office, Products and Services Provided
Table 54. Swine Respiratory Diseases Treatment Mergers & Acquisitions in the Past Five Years
Table 55. Swine Respiratory Diseases Treatment New Entrants and Expansion Plans
Table 56. Global Swine Respiratory Diseases Treatment Revenue (USD Million) by Type (2016-2021)
Table 57. Global Swine Respiratory Diseases Treatment Revenue Share by Type (2016-2021)
Table 58. Global Swine Respiratory Diseases Treatment Revenue Forecast by Type (2021-2026)
Table 59. Global Swine Respiratory Diseases Treatment Revenue by Application (2016-2021)
Table 60. Global Swine Respiratory Diseases Treatment Revenue Forecast by Application (2021-2026)
Table 61. North America Swine Respiratory Diseases Treatment Revenue by Type (2016-2021) & (USD Million)
Table 62. North America Swine Respiratory Diseases Treatment Revenue by Type (2021-2026) & (USD Million)
Table 63. North America Swine Respiratory Diseases Treatment Revenue by Application (2016-2021) & (USD Million)
Table 64. North America Swine Respiratory Diseases Treatment Revenue by Application (2021-2026) & (USD Million)
Table 65. North America Swine Respiratory Diseases Treatment Revenue by Country (2016-2021) & (USD Million)
Table 66. North America Swine Respiratory Diseases Treatment Revenue by Country (2021-2026) & (USD Million)
Table 67. Europe Swine Respiratory Diseases Treatment Revenue by Type (2016-2021) & (USD Million)
Table 68. Europe Swine Respiratory Diseases Treatment Revenue by Type (2021-2026) & (USD Million)
Table 69. Europe Swine Respiratory Diseases Treatment Revenue by Application (2016-2021) & (USD Million)
Table 70. Europe Swine Respiratory Diseases Treatment Revenue by Application (2021-2026) & (USD Million)
Table 71. Europe Swine Respiratory Diseases Treatment Revenue by Country (2016-2021) & (USD Million)
Table 72. Europe Swine Respiratory Diseases Treatment Revenue by Country (2021-2026) & (USD Million)
Table 73. Asia-Pacific Swine Respiratory Diseases Treatment Revenue by Type (2016-2021) & (USD Million)
Table 74. Asia-Pacific Swine Respiratory Diseases Treatment Revenue by Type (2021-2026) & (USD Million)
Table 75. Asia-Pacific Swine Respiratory Diseases Treatment Revenue by Application (2016-2021) & (USD Million)
Table 76. Asia-Pacific Swine Respiratory Diseases Treatment Revenue by Application (2021-2026) & (USD Million)
Table 77. Asia-Pacific Swine Respiratory Diseases Treatment Revenue by Region (2016-2021) & (USD Million)
Table 78. Asia-Pacific Swine Respiratory Diseases Treatment Revenue by Region (2021-2026) & (USD Million)
Table 79. South America Swine Respiratory Diseases Treatment Revenue by Type (2016-2021) & (USD Million)
Table 80. South America Swine Respiratory Diseases Treatment Revenue by Type (2021-2026) & (USD Million)
Table 81. South America Swine Respiratory Diseases Treatment Revenue by Application (2016-2021) & (USD Million)
Table 82. South America Swine Respiratory Diseases Treatment Revenue by Application (2021-2026) & (USD Million)
Table 83. South America Swine Respiratory Diseases Treatment Revenue by Country (2016-2021) & (USD Million)
Table 84. South America Swine Respiratory Diseases Treatment Revenue by Country (2021-2026) & (USD Million)
Table 85. Middle East & Africa Swine Respiratory Diseases Treatment Revenue by Type (2016-2021) & (USD Million)
Table 86. Middle East & Africa Swine Respiratory Diseases Treatment Revenue by Type (2021-2026) & (USD Million)
Table 87. Middle East & Africa Swine Respiratory Diseases Treatment Revenue by Application (2016-2021) & (USD Million)
Table 88. Middle East & Africa Swine Respiratory Diseases Treatment Revenue by Application (2021-2026) & (USD Million)
Table 89. Middle East & Africa Swine Respiratory Diseases Treatment Revenue by Country (2016-2021) & (USD Million)
Table 90. Middle East & Africa Swine Respiratory Diseases Treatment Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Swine Respiratory Diseases Treatment Picture
Figure 2. Global Swine Respiratory Diseases Treatment Revenue Market Share by Type in 2020
Figure 3. Mycoplasma
Figure 4. Bacteria
Figure 5. Virus
Figure 6. Others
Figure 7. Swine Respiratory Diseases Treatment Revenue Market Share by Application in 2020
Figure 8. Veterinary Hospitals Picture
Figure 9. Veterinary Clinics Picture
Figure 10. Pharmacies Picture
Figure 11. Others Picture
Figure 12. Global Swine Respiratory Diseases Treatment Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 13. Global Swine Respiratory Diseases Treatment Revenue and Forecast (2016-2026) & (USD Million)
Figure 14. Global Swine Respiratory Diseases Treatment Revenue Market Share by Region (2016-2026)
Figure 15. Global Swine Respiratory Diseases Treatment Revenue Market Share by Region in 2020
Figure 16. North America Swine Respiratory Diseases Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Europe Swine Respiratory Diseases Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Asia-Pacific Swine Respiratory Diseases Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. South America Swine Respiratory Diseases Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Middle East and Africa Swine Respiratory Diseases Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Swine Respiratory Diseases Treatment Market Drivers
Figure 22. Swine Respiratory Diseases Treatment Market Restraints
Figure 23. Swine Respiratory Diseases Treatment Market Trends
Figure 24. Zoetis Recent Developments and Future Plans
Figure 25. Virbac Recent Developments and Future Plans
Figure 26. Eli Lilly(Elanco) Recent Developments and Future Plans
Figure 27. Merck Animal Health Recent Developments and Future Plans
Figure 28. Boehringer Ingelheim Recent Developments and Future Plans
Figure 29. Ceva Sante Animale Recent Developments and Future Plans
Figure 30. Norbrook Recent Developments and Future Plans
Figure 31. Thermo Fisher Scientific Inc Recent Developments and Future Plans
Figure 32. Vetoquinol Recent Developments and Future Plans
Figure 33. Bimeda holdings PLC Recent Developments and Future Plans
Figure 34. Huvepharma Recent Developments and Future Plans
Figure 35. Global Swine Respiratory Diseases Treatment Revenue Share by Players in 2020
Figure 36. Swine Respiratory Diseases Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 37. Global Top 3 Players Swine Respiratory Diseases Treatment Revenue Market Share in 2020
Figure 38. Global Top 10 Players Swine Respiratory Diseases Treatment Revenue Market Share in 2020
Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 40. Global Swine Respiratory Diseases Treatment Revenue Share by Type in 2020
Figure 41. Global Swine Respiratory Diseases Treatment Market Share Forecast by Type (2021-2026)
Figure 42. Global Swine Respiratory Diseases Treatment Revenue Share by Application in 2020
Figure 43. Global Swine Respiratory Diseases Treatment Market Share Forecast by Application (2021-2026)
Figure 44. North America Swine Respiratory Diseases Treatment Sales Market Share by Type (2016-2026)
Figure 45. North America Swine Respiratory Diseases Treatment Sales Market Share by Application (2016-2026)
Figure 46. North America Swine Respiratory Diseases Treatment Revenue Market Share by Country (2016-2026)
Figure 47. United States Swine Respiratory Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Canada Swine Respiratory Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Mexico Swine Respiratory Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Europe Swine Respiratory Diseases Treatment Sales Market Share by Type (2016-2026)
Figure 51. Europe Swine Respiratory Diseases Treatment Sales Market Share by Application (2016-2026)
Figure 52. Europe Swine Respiratory Diseases Treatment Revenue Market Share by Country (2016-2026)
Figure 53. Germany Swine Respiratory Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. France Swine Respiratory Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. United Kingdom Swine Respiratory Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Russia Swine Respiratory Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Italy Swine Respiratory Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Asia-Pacific Swine Respiratory Diseases Treatment Sales Market Share by Type (2016-2026)
Figure 59. Asia-Pacific Swine Respiratory Diseases Treatment Sales Market Share by Application (2016-2026)
Figure 60. Asia-Pacific Swine Respiratory Diseases Treatment Revenue Market Share by Region (2016-2026)
Figure 61. China Swine Respiratory Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Japan Swine Respiratory Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South Korea Swine Respiratory Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. India Swine Respiratory Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Southeast Asia Swine Respiratory Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Australia Swine Respiratory Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. South America Swine Respiratory Diseases Treatment Sales Market Share by Type (2016-2026)
Figure 68. South America Swine Respiratory Diseases Treatment Sales Market Share by Application (2016-2026)
Figure 69. South America Swine Respiratory Diseases Treatment Revenue Market Share by Country (2016-2026)
Figure 70. Brazil Swine Respiratory Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Argentina Swine Respiratory Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Middle East and Africa Swine Respiratory Diseases Treatment Sales Market Share by Type (2016-2026)
Figure 73. Middle East and Africa Swine Respiratory Diseases Treatment Sales Market Share by Application (2016-2026)
Figure 74. Middle East and Africa Swine Respiratory Diseases Treatment Revenue Market Share by Country (2016-2026)
Figure 75. Turkey Swine Respiratory Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Saudi Arabia Swine Respiratory Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. UAE Swine Respiratory Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Methodology
Figure 79. Research Process and Data Source